[ Price : $8.95]
Kitov Pharmaceuticals Holdings completes FDA-required stability testing on nine pivotal batches of KIT-302, which the company says...[ Price : $8.95]
One week after the House passed the 21st Century Cures Act, the Senate votes 94 to 5 to pass the bill, and now sends it to Preside...[ Price : $8.95]
FDA associate commissioner Dana Corrigan says FDA is partnering with European Union regulatory authorities to expand drug manufact...[ Price : $8.95]
Senate Judiciary Committee members led by ranking member Patrick Leahy (D-VT) introduce a bipartisan amendment to prevent pharmace...[ Price : $8.95]
Two Knobbe Martens attorneys outline reasons why a federal appeals court upheld a lower court jury ruling that a reverse payment t...[ Price : $8.95]
CDER deputy director Douglas Throckmorton says FDA is working well with stakeholders to achieve goals on the safe and appropriate ...[ Price : $8.95]
Office of New Drug associate director Leah Christl says that biosimilar companies should be aware of various regulators requiremen...[ Price : $8.95]
In its latest release of Warning Letters, FDA cites Interquim, a Spanish active pharmaceutical ingredient maker.